Skip to content

A study to evaluate the anti-obesity effects of continuous intake with food containing multiple ingredients

A study to evaluate the anti-obesity effects of continuous intake with food containing multiple ingredients -A Randomized, double-blind, placebo-controlled parallel group study- - A study to evaluate the anti-obesity effects of continuous intake with food containing multiple ingredients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048605
Enrollment
80
Registered
2023-09-15
Start date
2022-08-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

FUKUOKA KINEN PET KENSHIN CENTER
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged 20-64 years when consented 2) Subjects with BMI >=23 kg/m2 and <30 kg/m2 at the time of screening test 3) Subjects who can visit on schedule days 4) Subjects who agree to participate in this study and can put signature and date to informed consent form by themselves prior to the study

Exclusion criteria

Exclusion criteria: 1) Subjects with a history of hepatic, renal, cardiac or organ disorders, diabetes or other serious diseases. 2) Subjects with a surgical history of digestive system (except appendicectomy). 3) Subjects currently under treatment with chronic diseases. 4) Subjects with food allergies to the food ingredients used in the study. 5) Subjects who wish to become pregnant during the study period or who are lactating or pregnant or may be pregnant. 6) Heavy drinkers (average amount of intake as pure alcohol is 60 g or more per day). 7) Subjects who take the supplement containing lactoferrin, mulberry extract, salacia extract, pueraria flower extract, irvingia gabonensis extract, DHA/EPA or rosehip extract, or general food such as protein diet, for 3 days or more per week and have continued to take it for 6 months or more. And the subjects who cannot stop taking the supplement or the general food during study periods (from application to last visit) 8) Subjects taking the medicines (for example the Bislat Gold EX or the Naishitol Za), the Chinese medicine (for example the Bofutsushosan or the Daisaikoto ) or the supplements claiming for the reduction of the body fat on diet. 9) Subjects who are participating in clinical trials or consumer monitoring other than this study or who are planning to participate during this study period. 10) Subjects who have donated 200 ml or more of blood after 1 month before the primary screening or plan to donate them before the end of the study separately from this study. 11) Subjects who frequently skip breakfast. 12) Subjects who work during 22:00 to 6:00 (shift worker, night- shift worker, etc including part-timer). 13) Subject who need to avoid consuming foods whose origin is not clearly indicated due to religious or other reasons. 14) Subjects judged as unsuitable for this study by the investigator with other reasons.

Design outcomes

Primary

MeasureTime frame
The area of abdominal total, visceral and subcutaneous fat

Secondary

MeasureTime frame
Triglyceride, Blood glucose, Body weight, BMI, Blood pressure, Body fat percentage, Waist circumference

Countries

Japan

Contacts

Public ContactIsao Takehara

Clinical Support Corporation Limited Food Service Division

takehara@csc-smo.co.jp011-223-3130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026